The latest news in rare cancer tumour types including sarcomas
Many patients with rare, fast-growing neuroendocrine tumours respond well to a common immunotherapy drug combination,…
Comprehensive profiling of tumour samples taken from patients with shows that multiple factors contribute to…
A new study led by researchers at the UCLA Jonsson Comprehensive Cancer Center, USA, found…
Working in close partnership with patients, scientists at the Broad Institute of MIT and Harvard,…
The U.S. Food and Drug Administration (FDA) granted accelerated approval to tazemetostat for the treatment…
Soft tissue sarcomas are a heterogenous group of aggressive, chemotherapy-resistant cancers that affect the soft…
Soft tissue sarcoma cells stop a key metabolic process which allows them to multiply and…
Research presented at the Clinical Oncology Society of Australia’s Annual Scientific Meeting shows that poor…
Fox Chase Cancer Center researchers have determined that RNA-based next generation sequencing picks up gene…
An experimental targeted drug could treat a rare type of cancer usually affecting the limbs,…